Related Experiment Video
Updated: Feb 1, 2026

Assaying the Kinase Activity of LRRK2 in vitro
Published on: January 18, 2012
Activating mutations in the MAP-kinase pathway define non-ossifying fibroma of bone
Daniel Baumhoer1, Michal Kovac1, Jan Sperveslage2
1Bone Tumour Reference Centre, Institute of Pathology, University Hospital Basel and University of Basel, Basel, Switzerland.
Abstract:
Non-ossifying fibroma (NOF), which occasionally results in pathologic fracture, is considered the most common benign and self-limiting lesion of the growing skeleton. By DNA sequencing we have identified hotspot KRAS, FGFR1 and NF1 mutations in 48 of 59 patients (81.4%) with NOF, at allele frequencies ranging from 0.04 to 0.61. Our findings define NOF as a genetically driven neoplasm caused in most cases by activated MAP-kinase signalling. Interestingly, this driving force either diminishes over time or at least is not sufficient to prevent autonomous regression and resolution. Beyond its contribution to a better understanding of the molecular pathogenesis of NOF, this study adds another benign lesion to the spectrum of KRAS- and MAP-kinase signalling-driven tumours. Copyright © 2018 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.
Insights
Non-ossifying fibroma (NOF) is a common benign bone lesion. Genetic mutations in KRAS, FGFR1, and NF1 were found in most NOF cases, indicating it is a genetically driven neoplasm.
Area of Science:
- Skeletal pathology
- Molecular genetics
- Oncology
Background:
- Non-ossifying fibroma (NOF) is the most common benign, self-limiting lesion of the growing skeleton.
- NOF can occasionally lead to pathologic fractures.
Purpose of the Study:
- To investigate the molecular pathogenesis of non-ossifying fibroma (NOF).
- To identify genetic mutations driving NOF development.
Main Methods:
- DNA sequencing was performed on 59 patients with NOF.
- Hotspot mutations in KRAS, FGFR1, and NF1 were analyzed.
Main Results:
- Mutations in KRAS, FGFR1, and NF1 were identified in 81.4% of patients (48/59) with NOF.
- Allele frequencies for these mutations ranged from 0.04 to 0.61.
- Findings suggest NOF is a genetically driven neoplasm, often involving activated MAP-kinase signaling.
Conclusions:
- Non-ossifying fibroma (NOF) is a genetically driven neoplasm, primarily caused by mutations activating the MAP-kinase signaling pathway.
- This study expands the understanding of benign lesions driven by KRAS and MAP-kinase signaling.
Related Concept Videos
Protein Kinases and Phosphatases
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
cAMP-dependent Protein Kinase Pathways
Mutations
Mutations
Chromosomal Alterations Are Large-Scale Mutations
While point mutations are changes in a single nucleotide in...
Viral Mutations
Mutation, Gene Flow, and Genetic Drift

